Ossiam Biogen Inc. Transaction History

Ossiam

$5.1 Billion
Q3 2024

A detailed history of Ossiam transactions in Biogen Inc. stock. As of the latest transaction made, Ossiam holds 47,710 shares of BIIB stock, worth $7.52 Million. This represents 0.18% of its overall portfolio holdings.

Number of Shares

47,710

Previous 40,951 16.51%

Holding current value

$7.52 Million

Previous $9.49 Million 2.58%

% of portfolio

0.18%

Previous 0.18%

24 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 13, 2024	BUY	$189.07 - $236.8 $1.28 Million - $1.6 Million	6,759 Added 16.51%	47,710 $9.25 Million
Q2 2024 Aug 13, 2024	BUY	$190.52 - $236.72 $2.98 Million - $3.7 Million	15,637 Added 61.77%	40,951 $9.49 Million
Q1 2024 May 13, 2024	SELL	$212.02 - $267.71 $700,938 - $885,049	-3,306 Reduced 11.55%	25,314 $5.46 Million
Q4 2023 Feb 13, 2024	SELL	$222.59 - $267.94 $1.06 Million - $1.27 Million	-4,746 Reduced 14.22%	28,620 $7.41 Million
Q3 2023 Nov 14, 2023	SELL	$253.3 - $285.89 $5.14 Million - $5.8 Million	-20,280 Reduced 37.8%	33,366 $8.58 Million
Q2 2023 Aug 11, 2023	BUY	$275.25 - $318.06 $4.32 Million - $4.99 Million	15,690 Added 41.34%	53,646 $15.3 Million
Q1 2023 May 12, 2023	BUY	$256.56 - $292.34 $32,583 - $37,127	127 Added 0.34%	37,956 $10.6 Million
Q4 2022 Feb 13, 2023	SELL	$252.44 - $306.72 $5.76 Million - $7 Million	-22,831 Reduced 37.64%	37,829 $10.5 Million
Q3 2022 Nov 14, 2022	SELL	$194.69 - $268.46 $740,211 - $1.02 Million	-3,802 Reduced 5.9%	60,660 $16.2 Million
Q2 2022 Aug 12, 2022	BUY	$187.54 - $223.02 $1.01 Million - $1.2 Million	5,393 Added 9.13%	64,462 $13.1 Million
Q1 2022 May 13, 2022	SELL	$193.77 - $244.14 $2.14 Million - $2.7 Million	-11,044 Reduced 15.75%	59,069 $12.4 Million
Q4 2021 Feb 14, 2022	BUY	$223.92 - $287.77 $4.77 Million - $6.13 Million	21,298 Added 43.63%	70,113 $16.8 Million
Q3 2021 Nov 12, 2021	BUY	$282.99 - $369.05 $2.26 Million - $2.95 Million	7,989 Added 19.57%	48,815 $13.8 Million
Q2 2021 Aug 13, 2021	SELL	$259.0 - $414.71 $5.16 Million - $8.27 Million	-19,934 Reduced 32.81%	40,826 $13.3 Million
Q1 2021 May 17, 2021	BUY	$242.95 - $284.63 $3.71 Million - $4.34 Million	15,256 Added 33.53%	60,760 $17 Million
Q4 2020 Feb 12, 2021	SELL	$236.26 - $355.63 $2.72 Million - $4.09 Million	-11,514 Reduced 20.19%	45,504 $11.1 Million
Q3 2020 Nov 12, 2020	BUY	$264.77 - $305.71 $500,944 - $578,403	1,892 Added 3.43%	57,018 $16.2 Million
Q2 2020 Aug 13, 2020	BUY	$258.66 - $342.55 $13.3 Million - $17.7 Million	51,563 Added 1447.18%	55,126 $14.7 Million
Q1 2020 May 14, 2020	BUY	$268.85 - $341.04 $880,483 - $1.12 Million	3,275 Added 1137.15%	3,563 $1.13 Million
Q4 2019 Feb 14, 2020	SELL	$220.06 - $304.07 $1.08 Million - $1.5 Million	-4,919 Reduced 94.47%	288 $85,000
Q3 2019 Nov 13, 2019	BUY	$217.44 - $243.88 $1.1 Million - $1.24 Million	5,080 Added 4000.0%	5,207 $1.21 Million
Q2 2019 Aug 13, 2019	SELL	$219.29 - $241.72 $2.24 Million - $2.47 Million	-10,206 Reduced 98.77%	127 $30,000
Q1 2019 May 15, 2019	BUY	$216.71 - $338.96 $298,626 - $467,086	1,378 Added 15.39%	10,333 $2.44 Million
Q4 2018 Feb 14, 2019	BUY	$278.5 - $352.75 $2.49 Million - $3.16 Million	8,955 New	8,955 $2.7 Million

Others Institutions Holding BIIB

# of Institutions

1,037

Shares Held

126M

Call Options Held

1.13M

Put Options Held

1.43M

View Full List

About BIOGEN INC.

Ticker BIIB
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 144,000,992
Market Cap $22.7B
Description
Biogen Inc. discovers, develops, manufactures, and delivers therapies for treating neurological and neurodegenerative diseases. The company offers TECFIDERA, VUMERITY, AVONEX, PLEGRIDY, TYSABRI, and FAMPYRA for multiple sclerosis (MS); SPINRAZA for spinal muscular atrophy; and FUMADERM to treat plaque psoriasis. It also provides BENEPALI, an eta...

More about BIIB

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Ossiam, based on Form 13F filings with the SEC.

News

Stay updated on Ossiam with notifications on news.

Account